Contact Information

Email: mgbadamosi@ufl.edu

Education

B.Sc, University of Delaware – Newark, DE

Entry date into PTR PhD Program: Fall 2017
Curriculum Vitae

Research Interests

• Pharmacogenomics
• Personalized Medicine
• AML
• Cancer Genomics
• Immunotherapy
• Pediatric Leukemia

Scholarship/Awards

• Graduate School Preeminence Award
• McKnight Graduate Fellowship Affiliate
• Board of Education Summer Fellowship

Professional Memberships

• American Society for Clinical Pharmacology and Therapeutics (ASCPT) 
• American Society of Hematology (ASH)
• National Organization for the Professional Advancement of Black Chemists and Chemical Engineers (NOBCChE)

Publications

• Gbadamosi M, Meishinchi S, Lamba JK. Gemtuzumab ozogamicin for treatment of newly diagnosed CD33-positive acute myeloid leukemia. Future Oncology. [In Review].